Global Rapid Influenza Diagnostic Test (RIDT) Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Scope of the Report:

The global Rapid Influenza Diagnostic Test (RIDT) market is valued at 1001.3 million USD in 2018 and is expected to reach 1377.3 million USD by the end of 2024, growing at a CAGR of 8.3% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Rapid Influenza Diagnostic Test (RIDT).
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Rapid Influenza Diagnostic Test (RIDT) market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Rapid Influenza Diagnostic Test (RIDT) market by product type and applications/end industries.

Market Segment by Companies, this report covers

Analytik Jena
Princeton BioMeditech Corporation
Roche
Abbot (Alere)
BD
Quidel
Sekisui Diagnostics
Meridian Bioscience
Thermo Fisher Scientific
BioMerieux
Response Biomedical
SA Scientific
DiaSorin (Focus Diagnostics)

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Digital RIDTs
Conventional RIDT

In 2018, Digital RIDTs accounted for a major share of 55.36% the global Rapid Influenza Diagnostic Test (RIDT) market. And this product segment is poised to reach 1039.09 million US$ by 2025 from 588.84 million US$ in 2018.

Market Segment by Application

s, can be divided into
Hospitals
POCT
Others

In Rapid Influenza Diagnostic Test (RIDT) market, the Hospitals holds an important share in terms of application, and it is expected to reach revenue of by 2025, at a CAGR of 8.37% during 2019 and 2025.

Frequently Asked Questions

What is the scope of the report?

This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

What are the key segments in the market?

By product type
By End User/Applications
By Technology
By Region

Which market dynamics affect the business?

The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.